STATEMENT OF CASH FLOWS	7 Months Ended
	Dec. 31, 2025 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (7,689,409)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares	8,264
Payment of operating costs through promissory note	10,420
Transaction costs charged to profit and loss	127,380
Cash and interest earned on cash and investments held in Trust Account	(768,884)
Change in fair value of Warrant Liabilities	(102,067)
Changes in operating assets and liabilities:
Other receivable	(39,927)
Prepaid expenses	(38,358)
Prepaid insurance	(68,750)
Long-term prepaid insurance	(75,000)
Deferred legal fee	16,935
Accounts payable and accrued expenses	7,083
Advisory fee payable	8,280,000
Net cash used in operating activities	(332,313)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(276,000,000)
Net cash used in investing activities	(276,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	275,750,000
Proceeds from sale of Private Placement Units	1,950,000
Underwriters' reimbursement	25,000
Proceeds from promissory note - related party	150,000
Repayment of promissory note - related party	(262,360)
Payment of offering costs	(467,435)
Net cash provided by financing activities	277,145,205
Net Change in Cash	812,892
Cash - End of period	812,892
Non-cash investing and financing activities:
Offering costs included in accrued offering costs	85,000
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	$ 16,736